≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Alcohol abuse counselling and surveillance

DOID Endpoint Browser

Z21_ALCOHOL_ABUSE_COUNSELLI_SURVE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Z71.4
  • Cause of death: ICD-10 — Z71.4

2 out of 7 registries used, show all original rules.

624

4. Check minimum number of events

None

624

5. Include endpoints

None

624

6. Filter based on genotype QC (FinnGen only)

624

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
4
Special
ALCOADVICE
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Z71

Similar endpoints

↥

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 624 215 409
Unadjusted period prevalence (%) 0.14 0.07 0.18
Median age at first event (years) 51.78 47.31 54.12

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
567
Matched controls
5667
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
+∞
323.0
567
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
25.9
203.6
309
250
Z00.0
ICD-10 Finland
General medical examination
12.1
142.7
319
546
Z71.8
ICD-10 Finland
Other specified counselling
8.1
108.0
323
800
N07BB01
ATC
disulfiram; oral
15.0
107.8
193
188
RD211
NOMESCO Finland
NA
24.8
103.0
149
80
P15
ICPC
Chronic alcohol abuse
21.1
101.8
156
100
SPAT1252
SPAT
Overall medication plan or its review
16.9
92.3
154
122
N05AH04
ATC
quetiapine; oral
7.3
88.7
262
594
HMAK
NOMESCO Finland
NA
8.6
86.6
216
377
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
13.3
80.2
149
148
SPAT1216
SPAT
Assessment of functional ability
8.9
79.3
190
304
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
8.3
71.2
176
290
Z3231
NOMESCO Finland
Registered nurse
5.3
69.2
285
910
N06AX11
ATC
mirtazapine; oral
5.0
68.1
310
1099
T36
ICD-10 Finland
Poisoning by systemic antibiotics
11.3
62.8
125
138
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
19.9
61.2
94
56
F10.20
ICD-10 Finland
Alcohol dependence currently independent
17.5
60.2
97
66
F10.24
ICD-10 Finland
Alcohol depence active use
22.3
58.4
86
45
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
18.1
57.4
91
59
F10.25
ICD-10 Finland
Alcohol dependence continuous use
16.8
55.0
90
63
F10.09
ICD-10 Finland
Alcohol intoxication UNS
16.3
53.8
89
64
SPAT1240
SPAT
Therapeutic discussion
6.2
52.0
159
337
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.5
51.0
175
426
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
11.0
50.8
101
109
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
4.1
50.7
266
996
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
12.4
49.3
92
87
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
25.2
47.5
67
30
SPAT1359
SPAT
Use of symptom diary
17.8
47.2
75
48
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
11.5
46.1
89
90
N05BA01
ATC
diazepam; systemic, rectal
5.2
43.5
152
370
WYA20
NOMESCO Finland
Home visit
28.4
43.4
59
23
N06AB04
ATC
citalopram; systemic
4.2
43.2
203
667
N05CF01
ATC
zopiclone; oral
3.7
43.0
249
981
SPAT1131
SPAT
Colonoscopy
14.5
42.4
73
57
N05AH03
ATC
olanzapine; systemic
6.6
40.3
112
204
SPAT1310
SPAT
Counselling related to known health issue
3.5
40.1
253
1052
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
22.9
40.1
58
28
SPAT1249
SPAT
Treatment-related counselling outside office
3.3
39.4
302
1451
S18
ICPC
Laceration/cut
3.3
38.3
297
1426
Z72.1
ICD-10 Finland
Alcohol use
21.0
38.3
57
30
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
17.4
38.3
61
39
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
5.8
38.2
119
250
SPAT1254
SPAT
Administration of medicine
5.0
37.7
135
332
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.2
37.4
108
206
N05BA04
ATC
oxazepam; oral
3.7
37.0
205
758
P16
ICPC
Acute alcohol abuse
15.0
36.7
62
46
SPAT1222
SPAT
Counselling/guidance promoting independent living
4.9
35.6
130
325
-1
NOMESCO Finland
NA
3.1
35.6
283
1362
N06AX16
ATC
venlafaxine; oral
4.2
35.1
154
462
N06AB10
ATC
escitalopram; oral
3.6
35.0
197
732
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
5.1
34.6
119
278
PLAK1
NOMESCO Finland
NA
33.9
34.0
44
14
F51.0
ICD-10 Finland
Nonorganic insomnia
4.4
33.1
135
375
K85.2
ICD-10 Finland
Alcohol-induced acute pancreatitis
39.0
31.9
40
11
C07AA05
ATC
propranolol; systemic
3.6
31.9
172
610
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.3
31.7
204
827
F41.1
ICD-10 Finland
Generalized anxiety disorder
8.0
31.5
74
104
AN2
HP
Balloon angioplasty, including several vessels
13.1
31.4
56
47
SPAT1234
SPAT
Support of social functional capacity
9.1
31.0
67
82
KHV
NOMESCO Finland
NA
49.3
31.0
37
8
SPAT1273
SPAT
Structured assessment of psychoactive substance / tobacco use
8.8
30.9
68
86
EBA00
NOMESCO Finland
Extraction of tooth
2.9
30.6
269
1340
Z71.5
ICD-10 Finland
Drug abuse counselling and surveillance
318.4
30.1
30
*
S06.0
ICD-10 Finland
Concussion
4.7
29.8
110
274
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
14.3
29.8
51
39
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
10.6
29.4
58
60
SPAT1307
SPAT
Psychosocial counselling and guidance
5.9
28.3
83
159
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
9.6
28.2
59
68
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.0
27.5
210
940
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
7.3
27.0
67
102
N06AB03
ATC
fluoxetine; oral
4.0
27.0
121
362
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.4
26.9
106
281
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
4.5
26.8
102
261
Z08
ICPC
Social welfare problem
17.8
25.7
40
24
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
9.4
25.7
54
63
S15
ICPC
Foreign body in skin
6.3
25.6
71
126
N06AB06
ATC
sertraline; oral
4.0
25.5
111
322
N03AX09
ATC
lamotrigine; oral
6.4
25.3
69
120
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
10.8
24.8
48
48
RF410
NOMESCO Finland
NA
18.4
24.7
38
22
P01
ICPC
Feeling anxious/nervous/tense
4.1
23.8
101
285
SPAT1149
SPAT
Suture or treatment of traumatic wound
4.0
23.8
105
307
P29
ICPC
Psychological sympt/compl other
5.2
23.8
77
165
SPAT1153
SPAT
Removal of sutures
2.7
23.7
206
981
S01.0
ICD-10 Finland
Open wound of scalp
4.7
23.6
86
209
SPAT1360
SPAT
Extensive global examination
5.1
23.5
78
172
Z3229
NOMESCO Finland
Other healthcare associate professional
4.7
23.3
85
207
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
4.0
23.1
101
293
A02BC02
ATC
pantoprazole; systemic
2.5
23.0
380
2550
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
12.9
22.7
40
33
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
16.6
22.6
36
23
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
11.0
22.5
43
42
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.5
22.4
69
139
L03
ICPC
Low back symptom/complaint
2.9
22.3
168
728
PLAK2
NOMESCO Finland
NA
26.3
22.0
30
12
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
15.3
21.9
36
25
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
11.9
21.8
40
36
RF420
NOMESCO Finland
NA
14.0
21.8
37
28
TLOPK
NOMESCO Finland
NA
119.6
21.7
23
*
N05AX12
ATC
aripiprazole; systemic
5.6
21.4
65
129
N03AG01
ATC
valproic acid; systemic, rectal
4.5
20.8
77
190
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
5.0
20.5
69
154
Z06
ICPC
Unemployment problem
24.5
20.1
28
12
N05BA02
ATC
chlordiazepoxide; systemic
7.4
19.9
48
70
SPAT1263
SPAT
Sampling
2.3
19.8
265
1552
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
7.9
19.6
45
61
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.6
19.5
170
793
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
5.8
19.5
57
108
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.2
19.2
77
205
N05AX08
ATC
risperidone; systemic
4.2
19.1
76
201
F29
ICD-10 Finland
Unspecified nonorganic psychosis
5.1
19.0
62
134
N05AF03
ATC
chlorprothixene; systemic
6.6
18.5
48
78
N05BA12
ATC
alprazolam; oral
3.7
18.4
87
267
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
9.4
18.4
38
43
SPAT1301
SPAT
No procedures
2.4
18.4
201
1053
SPAT1097
SPAT
Recording of ECG
3.3
18.4
102
355
N05CD07
ATC
temazepam; oral
3.9
18.2
80
231
WZC30
NOMESCO Finland
Teaching
3.2
18.2
105
376
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
8.4
18.1
40
51
S22.3
ICD-10 Finland
Fracture of rib
4.5
18.1
67
165
M79.6
ICD-10 Finland
Pain in limb
2.3
18.1
220
1216
SAA01
NOMESCO Finland
Simple examination of mouth
2.4
18.0
438
3335
N03AX12
ATC
gabapentin; oral
3.1
17.8
111
418
N05AA02
ATC
levomepromazine; systemic
5.1
17.7
57
121
N06AX12
ATC
bupropion; oral
4.0
17.6
74
205
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
10.0
17.6
35
37
N05CF02
ATC
zolpidem; oral
2.8
17.6
129
538
K70.1
ICD-10 Finland
Alcoholic hepatitis
25.0
17.4
24
10
N02BE01
ATC
paracetamol; systemic, rectal
2.6
17.2
486
3936
Z29
ICPC
Social problem NOS
11.2
17.2
32
30
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
5.6
17.1
51
99
T74.1
ICD-10 Finland
Physical abuse
7.0
17.0
42
64
SPAT1394
SPAT
Counselling and guidance related to living conditions
36.2
16.8
21
6
PLAK0
NOMESCO Finland
NA
36.2
16.8
21
6
K05.30
ICD-10 Finland
Periodontitis complex
3.2
16.7
94
329
Z72.2
ICD-10 Finland
Drug use
20.8
16.5
24
12
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
16.3
216
1228
SPAT1283
SPAT
Restricted health certificate
2.5
16.3
148
697
KMAK
NOMESCO Finland
NA
2.1
16.3
338
2332
N06AB05
ATC
paroxetine; oral
4.1
16.3
65
172
L28
ICPC
Limited function/disability (L)
3.4
16.2
85
283
R53
ICD-10 Finland
Malaise and fatigue
2.6
16.2
133
593
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
19.2
16.1
24
13
R1250
NOMESCO Finland
Evaluation of functional capability
7.9
15.9
36
48
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
10.9
15.9
30
29
Z72.8
ICD-10 Finland
Other problems related to lifestyle
87.5
15.6
17
*
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
9.9
15.6
31
33
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.6
15.5
74
229
SPAT1059
SPAT
Spirometry at the office
5.1
15.4
49
103
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
10.8
15.4
29
28
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.5
15.4
142
673
P19
ICPC
Drug abuse
16.6
15.4
24
15
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.1
15.3
310
2094
F34.1
ICD-10 Finland
Dysthymia
5.7
15.3
44
82
WX290
NOMESCO Finland
Other blockade of nerve
2.1
15.3
305
2048
PLAK3
NOMESCO Finland
NA
29.5
15.3
20
7
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.4
15.2
147
712
N05BE01
ATC
buspirone; oral
5.2
15.1
47
96
F41.09
ICD-10 Finland
UNS Panic Syndrome
6.3
15.1
40
67
TQW80
NOMESCO Finland
Local dermatologic skincare
7.5
15.0
35
49
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.0
14.8
348
2483
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
19.0
14.8
22
12
T51.0
ICD-10 Finland
Toxic effect: Ethanol
21.7
14.7
21
10
SPAT1281
SPAT
Other administrative function
3.8
14.7
65
188
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.9
14.6
96
373
Z03
ICPC
Housing/neighbourhood problem
17.5
14.4
22
13
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.7
14.4
109
461
SPAT1260
SPAT
Consultation of another employee
2.5
14.1
119
535
S82.6
ICD-10 Finland
Fracture of lateral malleolus
3.9
14.1
59
163
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.2
14.1
172
931
K92.0
ICD-10 Finland
Haematemesis
7.4
14.0
33
47
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
11.8
13.9
25
22
N03AE01
ATC
clonazepam; systemic
4.2
13.7
53
136
Z50.2
ICD-10 Finland
Alcohol rehabilitation
+∞
13.6
13
*
N05AN01
ATC
lithium; oral
6.2
13.5
36
61
RS311
NOMESCO Finland
NA
143.2
13.5
14
*
N02AX02
ATC
tramadol; systemic, rectal
2.0
13.5
245
1560
Z2445
NOMESCO Finland
Psychologist
4.5
13.5
48
114
N06AX22
ATC
agomelatine; oral
8.4
13.5
29
36
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
8.9
13.4
28
33
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
5.8
13.2
37
67
RF210
NOMESCO Finland
NA
5.9
13.1
36
64
XA800
NOMESCO Finland
Neuropsychological investigation
4.4
13.0
47
113
A46
ICD-10 Finland
Erysipelas
2.7
12.9
98
414
M54.5
ICD-10 Finland
Low back pain
2.0
12.8
211
1284
D19
ICPC
Teeth/gum symptom/complaint
2.1
12.8
174
980
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.3
12.7
66
218
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
8.5
12.7
27
33
C07AB07
ATC
bisoprolol; oral
2.0
12.7
227
1429
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
12.6
251
1643
F10.52
ICD-10 Finland
Psychotic alcohol hallucination
32.8
12.6
16
5
Z01
ICPC
Poverty/financial problem
32.8
12.6
16
5
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
17.8
12.6
19
11
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.8
12.4
84
331
EBA10
NOMESCO Finland
Surgical removal of tooth
2.6
12.4
101
443
RF120
NOMESCO Finland
NA
12.0
12.4
22
19
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
10.8
12.4
23
22
S00.0
ICD-10 Finland
Superficial injury of scalp
10.0
12.3
24
25
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
8.0
12.2
27
35
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.1
12.2
68
235
Y94.8
ICD-10 Finland
Other leisure activity accident
6.8
12.2
30
46
K02.1
ICD-10 Finland
Caries of dentine
1.9
12.2
353
2632
P03
ICPC
Feeling depressed
2.9
12.2
75
279
F31.8
ICD-10 Finland
Other bipolar affective disorders
6.5
12.1
31
50
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
18.5
12.1
18
10
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
12.1
11.9
21
18
SPAT1265
SPAT
Breathalyser
9.9
11.8
23
24
R11
ICD-10 Finland
Nausea and vomiting
3.4
11.8
57
178
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.7
11.7
51
147
V03AA01
ATC
NA
6.6
11.5
29
46
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
14.0
11.5
19
14
N06AX26
ATC
vortioxetine; oral
3.6
11.5
52
154
N02AA05
ATC
oxycodone; systemic
2.8
11.5
80
318
P74
ICPC
Anxiety disorder/anxiety state
4.3
11.5
42
103
RS340
NOMESCO Finland
NA
122.4
11.5
12
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.0
11.5
46
123
N06AX21
ATC
duloxetine; oral
2.8
11.4
76
295
XQ848
NOMESCO Finland
Dermatological photography
6.6
11.2
28
44
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
11.2
274
1903
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
25.6
11.2
15
6
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
6.9
11.1
27
41
SPAT1081
SPAT
Cardiorespiratory global assessment
4.4
11.1
40
97
F43.00
ICD-10 Finland
Acute stress reaction mild
6.2
11.0
29
49
A06AD11
ATC
lactulose; oral
2.8
11.0
74
289
W10
ICD-10 Finland
Fall on and from stairs and steps
4.1
10.9
42
108
F99
ICD-10 Finland
Mental disorder, not otherwise specified
5.6
10.9
31
58
SPAT1098
SPAT
Exercise ECG
7.4
10.9
25
35
R05
ICPC
Cough
2.2
10.8
128
671
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
10.8
232
1532
SPAT1212
SPAT
Extensive examination of musculoskeletal system
3.2
10.8
56
185
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
18.2
10.8
16
9
SPAT1106
SPAT
Acupuncture
22.0
10.7
15
7
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
22.0
10.7
15
7
SPAT1247
SPAT
Outpatient detoxication and monitoring
13.2
10.7
18
14
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.8
10.6
313
2296
N06AA12
ATC
doxepin; systemic
4.2
10.6
40
101
P76
ICPC
Depressive disorder
3.2
10.6
57
193
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.3
10.6
100
474
N06AA09
ATC
amitriptyline; systemic
3.0
10.5
60
212
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.2
10.3
119
617
R51.80
ICD-10 Finland
Headache
2.4
10.2
95
444
R41.0
ICD-10 Finland
Disorientation, unspecified
7.1
10.2
24
35
N05AD03
ATC
melperone; systemic
11.6
10.1
18
16
K05.31
ICD-10 Finland
Periodontitis pronounced
2.8
10.1
69
271
K86.3
ICD-10 Finland
Pseudocyst of pancreas
14.9
10.0
16
11
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
14.9
10.0
16
11
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
3.8
10.0
42
117
Y94
ICD-10 Finland
Leisure accident
40.8
10.0
12
*
M10.9
ICD-10 Finland
Gout, unspecified
3.5
9.9
45
135
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
26.5
9.8
13
5
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
4.4
9.8
35
84
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
7.6
9.8
22
30
N06AX05
ATC
trazodone; oral
5.4
9.6
28
54
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.8
9.6
244
1687
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.7
9.6
68
276
P99
ICPC
Psychological disorders other
4.5
9.6
33
77
H13
ICPC
Plugged feeling ear
2.3
9.4
95
462
D11
ICPC
Diarrhoea
2.5
9.4
76
331
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
17.9
9.4
14
8
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
9.4
119
640
Y94.0
ICD-10 Finland
Accident at home
8.2
9.4
20
25
F05.9
ICD-10 Finland
Delirium, unspecified
8.9
9.4
19
22
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
9.3
141
814
RS222
NOMESCO Finland
NA
10.9
9.3
17
16
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
10.9
9.3
17
16
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.8
9.3
248
1738
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.1
9.3
35
89
F40.1
ICD-10 Finland
Social phobias
5.0
9.3
29
61
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
9.3
106
545
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.6
9.3
69
288
SPAT1229
SPAT
Assessment of need for aid
3.6
9.2
41
121
RS221
NOMESCO Finland
NA
6.4
9.2
23
37
K85
ICD-10 Finland
Acute pancreatitis
6.1
9.1
24
41
K05
ICPC
Irregular heartbeat other
6.1
9.1
24
41
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
9.3
9.1
18
20
B18.2
ICD-10 Finland
Chronic viral hepatitis C
6.7
9.0
22
34
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.2
9.0
96
479
ZYY79
SPAT
NA
24.4
8.9
12
5
WZA90
NOMESCO Finland
Other doctors statement
1.9
8.9
141
829
P06
ICPC
Sleep disturbance
2.5
8.9
71
306
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
6.8
8.7
21
32
F10.04
ICD-10 Finland
Alcohol-related acute intoxication with hallucinations
50.8
8.7
10
*
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
2.8
8.7
56
215
T90
ICPC
Diabetes non-insulin dependent
2.0
8.7
124
697
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.6
8.5
37
107
SAA02
NOMESCO Finland
Basic examination of mouth
1.7
8.5
369
2955
X58
ICD-10 Finland
Exposure to other specified factors
2.1
8.5
97
498
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
8.5
266
1938
N06AX03
ATC
mianserin; oral
3.4
8.4
39
119
F43.1
ICD-10 Finland
Post-traumatic stress disorder
6.9
8.4
20
30
N05AB01
ATC
dixyrazine; systemic
6.9
8.4
20
30
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
6.9
8.4
20
30
D10
ICPC
Vomiting
3.1
8.4
47
162
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
6.0
8.4
22
38
F39
ICD-10 Finland
Unspecified mood [affective] disorder
6.0
8.4
22
38
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
8.4
81
386
P18
ICPC
Medication abuse
11.0
8.3
15
14
R5140
NOMESCO Finland
Monitoring the use of the aid
2.3
8.3
79
374
-42
ICPC
Electrical tracing
9.6
8.3
16
17
A03
ICPC
Fever
2.0
8.3
107
578
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.6
8.2
36
105
NHU10
NOMESCO Finland
Removal of external fixation device from ankle or foot
14.7
8.2
13
9
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
14.7
8.2
13
9
A04
ICPC
Weakness/tiredness general
2.6
8.2
60
248
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
6.2
8.2
21
35
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.7
8.2
334
2613
J45.8
ICD-10 Finland
Mixed asthma
5.2
8.1
24
48
N03AX16
ATC
pregabalin; oral
1.9
8.1
130
765
RJ190
NOMESCO Finland
NA
22.4
8.0
11
5
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.1
7.9
42
142
F10.3
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state
13.3
7.9
13
10
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
4.8
7.9
25
54
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
7.9
216
1507
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
7.9
49
182
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
11.0
7.8
14
13
Z51.0
ICD-10 Finland
Radiotherapy session
11.0
7.8
14
13
X78
ICD-10 Finland
Intentional self-harm by sharp object
11.0
7.8
14
13
K08.3
ICD-10 Finland
Retained dental root
2.8
7.8
50
191
N06AG02
ATC
moclobemide; oral
3.4
7.8
36
110
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
5.2
7.8
23
46
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
7.8
164
1053
P27
ICPC
Fear of mental disorder
6.5
7.8
19
30
309
Kela drug reimbursment
Nalmefene and naltrexone
15.3
7.7
12
8
R52.2
ICD-10 Finland
Other chronic pain
4.5
7.7
26
60
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
7.6
7.7
17
23
SPAT1312
SPAT
General health counselling
1.8
7.7
169
1098
TKC20
NOMESCO Finland
Catheterisation of bladder
3.0
7.6
43
150
R55
ICD-10 Finland
Syncope and collapse
2.5
7.5
58
246
F60.9
ICD-10 Finland
Personality disorder, unspecified
4.9
7.5
23
48
ECB00
NOMESCO Finland
Suture of gingiva
3.7
7.5
31
87
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
5.2
7.5
22
44
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.2
7.5
73
350
S01.9
ICD-10 Finland
Open wound of head, part unspecified
6.6
7.5
18
28
S01.51
ICD-10 Finland
Open wound on lip
6.6
7.5
18
28
Y96.9
ICD-10 Finland
Unspecified type of accident
5.4
7.4
21
40
JONO
NOMESCO Finland
NA
7.8
7.4
16
21
A44
ICPC
General and Unspecified, Preventive immunization/medic
2.8
7.4
47
178
S42.0
ICD-10 Finland
Fracture of clavicle
3.9
7.4
29
78
Z11
ICPC
Compliance/being ill problem
8.5
7.4
15
18
K78
ICPC
Atrial fibrillation/flutter
3.2
7.3
36
116
WX110
NOMESCO Finland
Local anesthesy
1.7
7.3
387
3199
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
16.0
7.2
11
7
WW200
SPAT
NA
0.2
7.2
8
360
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.2
7.2
36
118
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
30.4
7.2
9
*
F90.0
ICD-10 Finland
Disturbance of activity and attention
4.0
7.2
27
70
Z72.0
ICD-10 Finland
Tobacco use
4.0
7.2
27
70
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
20.3
7.2
10
5
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
20.3
7.2
10
5
S02.30
ICD-10 Finland
Fracture of orbital floor, closed
12.2
7.1
12
10
OAB43
SPAT
NA
0.4
7.1
32
726
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
7.0
94
512
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
7.0
110
640
S92.3
ICD-10 Finland
Fracture of metatarsal bone
3.8
7.0
28
77
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.5
6.9
31
93
R07
ICPC
Sneezing/nasal congestion
2.7
6.9
46
181
L01
ICPC
Neck symptom/complaint
2.1
6.9
74
370
P72
ICPC
Schizophrenia
4.5
6.9
23
53
NGJ70
NOMESCO Finland
External fixation of fracture of knee or lower leg, other or unspecified
14.0
6.9
11
8
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
4.3
6.9
24
58
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
11.1
6.8
12
11
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
11.1
6.8
12
11
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
6.8
107
622
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.7
6.8
28
79
RS313
NOMESCO Finland
NA
16.9
6.8
10
6
RS121
NOMESCO Finland
NA
16.9
6.8
10
6
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
3.5
6.7
29
85
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
6.7
66
318
F10
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol
22.8
6.7
9
*
C07AB05
ATC
betaxolol; oral
6.6
6.7
16
25
Y25
ICPC
Fear sexually transm disease male
3.7
6.7
27
75
R06.0
ICD-10 Finland
Dyspnoea
1.9
6.7
112
664
EBA30
NOMESCO Finland
Excision of root of tooth
2.9
6.7
39
142
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
4.7
6.6
21
46
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
12.4
6.6
11
9
RJ410
NOMESCO Finland
NA
12.4
6.6
11
9
W19
ICD-10 Finland
Unspecified fall
2.4
6.5
55
246
F31
ICD-10 Finland
Bipolar affective disorder
5.8
6.5
17
30
S70.0
ICD-10 Finland
Contusion of hip
4.2
6.5
23
57
RS310
NOMESCO Finland
NA
70.6
6.4
7
*
R07.3
ICD-10 Finland
Other chest pain
2.6
6.4
45
182
F32.1
ICD-10 Finland
Moderate depressive episode
2.8
6.4
39
146
Z2446
NOMESCO Finland
Social worker
2.5
6.4
48
201
U04
ICPC
Incontinence urine
4.5
6.4
21
48
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
4.5
6.4
21
48
C08CA01
ATC
amlodipine; oral
1.7
6.3
157
1050
K85.8
ICD-10 Finland
Other acute pancreatitis
11.2
6.3
11
10
F60.2
ICD-10 Finland
Dissocial personality disorder
11.2
6.3
11
10
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
11.2
6.3
11
10
RS230
NOMESCO Finland
NA
11.2
6.3
11
10
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
6.3
96
550
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
9.4
6.3
12
13
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
18.2
6.3
9
5
K22
ICPC
Risk factor cardiovascular disease
3.1
6.3
32
107
N05AD01
ATC
haloperidol; systemic
3.9
6.2
24
64
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
6.4
6.2
15
24
RF220
NOMESCO Finland
NA
6.4
6.2
15
24
X23
ICPC
Fear sexually transm dis female
3.1
6.2
32
108
K92.1
ICD-10 Finland
Melaena
3.4
6.1
27
81
C03CA01
ATC
furosemide; systemic
1.9
6.1
96
555
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
6.1
76
404
S10
ICPC
Boil/carbuncle
2.8
6.1
37
139
R02
ICPC
Shortness of breath/dyspnoea
2.2
6.1
61
294
F32
ICD-10 Finland
Depressive episode
2.7
6.1
39
150
F61.0
ICD-10 Finland
Mixed personality disorders
4.0
6.0
22
56
NGU20
NOMESCO Finland
Removal of internal fixation device from knee or lower leg
4.6
6.0
19
42

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021589) Normoblasts [#/volume] in Blood
457
2249
4.86
72.38
10.7
9.0
e9/l
0.0
0.0
0.04
430
1856
(3025159) Blasts/100 leukocytes in Blood
162
364
5.66
71.27
4.7
5.0
%
0.1
0.2
0.34
23
96
(3002179) Metamyelocytes/100 leukocytes in Blood
163
376
5.51
69.50
4.7
4.5
%
0.9
0.4
1.17
23
94
(3021440) Promyelocytes/100 leukocytes in Blood
164
383
5.45
68.91
4.7
4.9
%
0.1
0.2
0.19
23
112
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
259
902
4.20
65.06
3.0
2.0
%
2.0
1.5
7.36
235
810
(3017181) Myelocytes/100 leukocytes in Blood
164
410
5.07
63.23
4.7
4.8
%
1.2
0.8
0.50
23
123
(3009542) Hematocrit [Volume Fraction] of Blood
323
4992
0.27
57.16
17.6
13.1
%
40.0
41.4
2.20
254
3952
(3023183) Ammonium ion [Moles/volume] in Plasma
76
111
7.66
50.71
3.4
4.1
umol/l
31.6
37.2
1.19
69
96
(3020191) Ethanol [Moles/volume] in Serum or Plasma
50
51
10.57
44.17
2.6
1.3
promille
2.4
1.5
2.39
41
41
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
317
1540
3.15
43.55
5.3
2.6
u/l
74.2
57.0
1.83
310
1442
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
143
435
3.97
41.40
3.7
2.4
g/l
0.2
0.2
5.63
135
406
(3028707) Methadone [Presence] in Urine by Screen method
74
135
6.08
39.74
4.2
4.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
34
24
14.93
37.62
2.0
2.3
umol/l
175.2
86.3
0.94
17
12
(3011288) Drugs identified in Urine by Screen method
87
205
4.77
34.98
5.5
4.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
93
239
4.40
33.48
3.7
2.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
408
2520
2.79
32.43
8.1
6.7
umol/l
14.5
11.4
1.50
396
2399
(3044242) Glucose [Moles/volume] in Arterial blood
30
23
13.65
31.61
2.1
4.2
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
32
30
11.19
29.77
3.7
2.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
96
279
3.88
29.11
3.7
3.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
28
23
12.70
28.28
2.2
4.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
99
301
3.72
28.08
3.6
2.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
99
304
3.68
27.65
3.6
2.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
99
304
3.68
27.65
3.7
2.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
352
2135
2.49
27.20
7.1
7.4
mmol/l
1.2
1.2
1.76
334
1828
(44816559) Phosphatidylethanol [Mass/volume] in Blood
64
148
4.70
26.15
1.9
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
315
1871
2.38
24.76
9.2
7.8
inr
1.2
1.2
0.10
180
570
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
185
864
2.62
24.61
1.6
1.6
pmol/l
493.7
35067082.1
0.97
172
750
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
299
1790
2.29
22.42
4.0
3.2
ng/l
29.4
40.7
0.68
241
1138
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
247
1384
2.30
21.48
2.6
2.1
u/l
663.6
256.0
0.54
240
1319
(3027944) Amphetamines [Presence] in Urine
89
303
3.26
20.95
3.7
2.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
500
3790
2.61
20.66
9.8
7.8
u/l
83.9
77.7
2.03
494
3591
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
585
4906
4.08
18.47
14.5
11.0
ml/min/173m2
90.2
87.6
2.20
554
4051
(3024354) Oxygen [Partial pressure] in Venous blood
92
352
2.89
17.59
3.4
2.9
kpa
4.7
4.7
0.05
84
342
(3021960) Folate [Moles/volume] in Serum or Plasma
179
953
2.23
16.92
1.5
1.5
nmol/l
19.2
20.0
0.31
160
833
(3023368) Bacteria identified in Blood by Culture
213
1239
2.09
15.89
3.8
4.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
247
1525
2.03
15.60
3.6
3.4
mmol/l
7.6
8.7
2.67
223
1300
(3017143) Hepatitis C virus Ab [Presence] in Serum
142
718
2.27
15.01
1.7
1.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
98
420
2.58
14.95
3.7
3.7
kpa
6.0
5.9
0.52
91
410
(3029937) Albumin [Presence] in Urine by Test strip
209
1253
2.00
14.04
3.2
3.3
estimate
0.0
0.0
0.88
165
436
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
180
1028
2.06
13.81
2.2
2.0
mg/l
3.2
3.0
0.55
168
884
(3003181) Sodium [Moles/volume] in Urine
28
56
5.19
13.48
1.2
1.3
mmol/l
63.9
60.6
0.12
16
49
(4198724)
21
34
6.36
12.54
3.0
2.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
129
681
2.13
12.03
2.1
2.5
umol/l
12.9
14.1
0.93
119
638
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
23
43
5.52
11.90
1.3
2.3
pg
34.3
34.0
0.12
23
43
(3022313) Gas panel - Capillary blood
60
227
2.82
11.62
3.7
3.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
120
634
2.11
11.11
2.0
2.5
g/l
2.3
2.4
0.09
112
593
(3022096) Basophils/100 leukocytes in Blood
312
2263
1.76
10.72
5.7
6.4
%
0.8
0.7
1.98
295
2149
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
112
585
2.11
10.65
2.1
2.6
%
24.7
24.1
0.11
100
508
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
69
294
2.51
10.56
4.0
3.1
mmol/l
1.3
1.4
0.05
47
215
(3019309) Folate [Moles/volume] in Red Blood Cells
124
675
2.04
10.56
1.8
1.6
nmol/l
1230.3
1185.8
0.19
99
536
(3006504) Eosinophils/100 leukocytes in Blood
318
2330
1.74
10.45
5.6
6.4
%
2.8
2.9
0.37
300
2205
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
19
34
5.73
10.28
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
19
34
5.73
10.28
1.1
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
319
2347
1.73
10.27
5.8
6.7
%
9.2
8.7
1.76
303
2236
(3002385) Erythrocyte distribution width [Ratio]
519
4433
2.01
9.80
16.4
15.2
%
13.9
13.6
4.83
514
4344
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
152
918
1.87
9.46
1.6
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
39
131
3.11
9.32
1.5
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
320
2401
1.68
9.23
5.7
6.2
%
56.9
56.8
0.05
303
2291
(3006922) Hepatitis E virus Ab [Presence] in Serum
19
38
5.13
9.14
1.1
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
256
1826
1.68
8.84
2.2
2.2
nmol/l
68.3
73.0
1.63
238
1668
(3026782) Osmolality of Urine
144
874
1.84
8.76
2.7
2.5
mosm/kgh2o
431.8
575.1
12.15
139
755
(3019225) pH of Specimen
80
396
2.17
8.67
4.2
4.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
269
1951
1.67
8.66
6.6
6.6
mmol/l
1.2
1.2
3.56
248
1800
(40761511) CBC panel - Blood by Automated count
600
5506
3.33
8.57
16.4
11.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
320
2439
1.64
8.39
5.7
6.4
%
27.3
28.3
1.06
305
2317
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
32
102
3.25
8.34
1.1
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
27
77
3.62
8.33
3.4
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
183
1208
1.73
8.32
5.1
4.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
91
483
2.03
8.21
7.8
9.7
%
94.9
95.8
0.56
91
468
(3024561) Albumin [Mass/volume] in Serum or Plasma
262
1910
1.64
8.13
5.0
5.4
g/l
34.1
36.4
7.74
253
1804
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
304
2313
1.61
7.85
3.8
4.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
27
740
0.34
7.74
1.3
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
202
1392
1.67
7.74
3.2
2.7
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
96
533
1.95
7.61
7.7
9.2
kpa
5.1
5.1
0.01
96
513
(3006315) Basophils [#/volume] in Blood
322
2497
1.60
7.59
5.5
6.4
e9/l
0.0
0.0
1.74
286
2197
(3013115) Eosinophils [#/volume] in Blood
330
2578
1.59
7.51
5.8
6.7
e9/l
0.2
0.2
0.16
295
2311
(3034770) Mitochondria Ab [Titer] in Serum
42
167
2.62
7.42
1.5
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
319
2490
1.58
7.16
5.5
6.3
e9/l
0.7
0.6
4.57
287
2190
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
24
664
0.34
6.98
1.2
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
21
59
3.65
6.64
1.1
1.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
325
2583
1.54
6.49
5.6
6.4
e9/l
1.9
2.0
0.30
296
2314
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
27
682
0.37
6.46
1.6
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
77
419
1.96
6.45
4.1
3.7
mmol/l
2.3
2.0
0.32
59
336
(3008402) Methanol [Moles/volume] in Serum or Plasma
10
7
14.49
6.41
2.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
10
15
6.76
6.33
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
10
15
6.76
6.33
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
10
15
6.76
6.33
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
10
15
6.76
6.33
1.1
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
566
5180
2.00
6.03
16.9
12.7
mg/l
21.6
23.2
0.50
506
4057
(3028626) Oxygen [Partial pressure] in Capillary blood
27
95
2.93
6.01
3.4
2.2
kpa
8.4
8.3
0.13
27
90
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
447
3845
1.57
5.99
7.5
3.2
u/l
101.5
51.3
7.39
432
3645
(3012095) Magnesium [Moles/volume] in Serum or Plasma
121
775
1.70
5.94
3.6
3.6
mmol/l
0.8
0.8
1.96
116
737
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
58
294
2.07
5.92
1.3
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
111
704
1.70
5.64
2.1
2.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
12
25
4.87
5.51
1.0
1.1
nmol/l
157.2
153.8
0.07
12
25
(3023520) Reticulocytes [#/volume] in Blood
63
338
1.96
5.51
2.0
3.0
e9/l
84.5
72.4
1.68
53
259
(3012516) Albumin [Mass/volume] in Urine
186
1347
1.54
5.48
2.8
3.3
mg/l
315.8
259.2
0.07
149
906
(3001122) Ferritin [Mass/volume] in Serum or Plasma
265
2070
1.49
5.43
2.6
2.7
ug/l
175.8
141.7
0.69
253
1932
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
45
216
2.17
5.29
4.8
4.1
mmol/l
24.3
24.3
0.04
32
198
(40768797) Stomach Pathology biopsy report
101
641
1.69
5.10
1.3
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
347
2881
1.46
5.09
7.2
9.7
e9/l
4.5
4.1
1.57
317
2540
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
18
56
3.28
4.93
1.7
1.4
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
19
63
3.08
4.71
1.2
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
136
2.35
4.52
1.6
1.4
ug/g
250.7
282.0
0.30
23
75
(3027945) Reticulocytes/100 erythrocytes in Blood
76
461
1.74
4.52
1.9
2.8
%
2.2
1.8
2.03
69
426
(3020682) Albumin/Creatinine [Ratio] in Urine
188
1416
1.47
4.45
3.1
4.0
mg/mmol
6.1
11.0
1.63
149
937
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
9
287
0.30
4.34
10.2
2.9
ng/l
102.8
159.4
—
9
256
(3016650) Hepatitis A virus Ab [Presence] in Serum
26
108
2.47
4.28
1.2
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
69
415
1.75
4.23
1.8
2.4
g/l
12.4
10.5
2.40
61
378
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
26
110
2.42
4.12
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
86
555
1.64
4.07
3.4
6.6
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
8
10
8.09
4.07
2.3
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
175
2245
0.69
4.04
1.6
2.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
129
917
1.51
4.02
2.6
2.3
e6/l
5.1
4.8
0.06
122
816
(3026008) Bacteria identified in Urine by Culture
145
1056
1.49
4.02
3.2
2.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
66
1038
0.59
3.96
1.2
1.5
—
—
—
0
0
(3020891) Body temperature
39
200
2.01
3.91
8.4
4.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
24
4.22
3.90
1.1
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
417
3672
1.41
3.89
3.2
3.6
pmol/l
14.8
14.6
0.59
398
3379
(3033658) Prothrombin time (PT) actual/Normal
167
1259
1.45
3.87
5.7
3.9
%
86.2
92.1
2.18
162
1237
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
154
1145
1.46
3.83
4.0
2.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
239
0.28
3.80
1.9
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
69
1062
0.61
3.79
2.6
3.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
327
3757
0.73
3.74
2.9
3.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
20
453
0.42
3.72
1.4
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
25
4.05
3.71
1.0
1.0
miu/ml
1581.5
1382.9
—
10
25
(40761536) Microorganisms panel - Urine sediment
17
411
0.40
3.70
4.7
3.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
45
250
1.86
3.60
1.8
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
90
0.00
3.52
0.0
1.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
42
3.14
3.38
1.5
2.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
102
715
1.51
3.38
1.9
1.9
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
18
5.06
3.38
3.1
2.1
—
—
—
0
0
(3000012) Reticulocyte production index
8
14
5.77
3.35
1.0
2.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
28
3.61
3.20
1.0
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
408
3639
1.35
3.14
3.8
3.8
mm/h
14.3
9.9
6.56
388
3412
(3014271) Vancomycin [Susceptibility]
9
20
4.55
3.12
2.0
2.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
200
0.29
3.12
1.2
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
210
1707
1.35
3.01
2.2
1.8
pmol/l
95.7
95.1
0.06
136
937
(3037522) Nuclear Ab [Titer] in Serum
96
682
1.48
2.99
1.5
1.4
titre
305.5
401.4
0.82
22
141
(46235355) HIV 1 and 2 tests - Meaningful Use set
150
1158
1.39
2.97
2.1
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
81
556
1.52
2.97
4.2
4.1
%
29.6
29.7
0.01
63
388
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
71
474
1.56
2.94
5.4
2.6
u/l
34.8
135.3
0.51
59
413
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
17
4.75
2.92
3.0
4.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
83
575
1.51
2.91
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
35
598
0.56
2.86
1.4
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
47
2.80
2.83
2.1
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
32
173
1.90
2.82
2.5
2.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
77
529
1.52
2.81
8.8
9.3
mmol/l
1.3
0.9
0.38
67
430
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
107
786
1.44
2.80
2.0
2.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
220
1817
1.33
2.79
4.1
3.7
u/l
44.6
34.1
2.34
213
1729
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
85
2.27
2.73
5.3
3.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
85
2.27
2.73
1.8
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
584
5592
1.69
2.69
13.2
9.8
u/l
33.0
30.6
1.48
578
5447
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
30
162
1.89
2.67
2.4
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
60
880
0.65
2.64
5.3
3.6
ng/l
151.8
554.5
1.48
40
642
(3033799) Differential panel - Peritoneal fluid
6
11
5.50
2.55
1.3
2.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
29
159
1.86
2.48
2.3
4.2
g/l
0.2
0.2
0.24
14
83
(3019150) Specific gravity of Urine by Refractometry
77
1061
0.69
2.47
3.2
3.3
kg/l
1.0
1.0
—
5
144
(4034850)
6
176
0.33
2.44
12.0
10.8
—
—
—
0
0
(44790048)
0
63
0.00
2.44
0.0
1.7
—
—
—
0
0
(44806118)
0
63
0.00
2.44
0.0
1.7
—
—
—
0
0
(44790047)
0
63
0.00
2.44
0.0
1.7
—
—
—
0
0
(44790049)
0
63
0.00
2.44
0.0
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
21
104
2.05
2.39
1.1
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
156
1253
1.33
2.36
2.9
2.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
41
2.71
2.29
1.1
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
59
0.00
2.25
0.0
1.5
—
388.8
—
0
48
(3011985) Renin [Units/volume] in Plasma
0
61
0.00
2.24
0.0
1.4
—
56.3
—
0
53
(3039443) Prostate specific Ag panel - Serum or Plasma
9
213
0.41
2.23
1.3
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
222
1888
1.27
2.16
3.2
3.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
13
278
0.46
2.16
3.5
2.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
10
237
0.41
2.15
2.8
2.3
e6/l
0.0
0.2
—
10
227
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
144
1158
1.32
2.15
2.2
2.9
ng/l
1075.4
915.1
0.31
115
955
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
275
0.46
2.10
1.5
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
14
62
2.29
2.09
2.6
3.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
20
103
1.97
2.07
1.3
1.1
iu/ml
1.0
21.7
—
8
26
(3020630) Protein [Mass/volume] in Serum or Plasma
47
312
1.55
2.05
1.4
2.7
g/l
67.2
66.9
0.07
42
295
(42870588) Differential panel, method unspecified - Blood
135
1655
0.76
2.04
6.3
6.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
38
2.66
2.02
1.0
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
155
1272
1.29
1.98
3.0
2.8
e6/l
0.4
0.4
0.03
127
945
(3028433) Virus identified in Specimen by Culture
7
21
3.36
1.97
1.0
1.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
11
4.57
1.94
1.4
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
9
33
2.75
1.93
2.1
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
251
0.47
1.90
1.3
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
96
1223
0.75
1.90
5.3
7.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
51
0.00
1.89
0.0
1.5
—
68.8
—
0
5
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
51
0.00
1.89
0.0
4.2
—
24.3
—
0
13
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
51
0.00
1.89
0.0
2.6
—
40.0
—
0
14
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
7
22
3.21
1.88
2.9
3.0
—
29.1
—
0
5
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
19
100
1.93
1.87
1.6
1.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
9
34
2.67
1.87
1.0
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
178
1497
1.26
1.86
3.9
2.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
235
0.46
1.85
1.0
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
481
4522
1.28
1.82
4.0
4.2
mu/l
1.9
2.4
0.72
452
4201
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
385
0.58
1.80
2.6
2.4
ml/min/173m2
70.1
72.6
—
8
156
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
137
1121
1.28
1.79
1.2
1.2
u/ml
1.2
1.2
0.05
66
338
(4146454)
11
47
2.36
1.78
2.3
2.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
160
1339
1.26
1.74
2.9
2.6
ug/l
0.8
0.7
0.51
89
780
(40768441) Liver Pathology biopsy report
10
42
2.40
1.68
2.0
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
145
0.41
1.66
1.5
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
145
0.41
1.66
1.5
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
363
3325
1.22
1.66
4.1
3.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
57
415
1.41
1.62
1.9
4.9
ug/l
4.2
38.7
1.07
46
347
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
14
3.59
1.62
1.4
1.6
umol/l
17.0
15.7
—
5
14
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
68
511
1.37
1.61
3.4
4.3
u/l
246.0
239.6
0.16
62
487
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
20
3.02
1.58
1.2
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
20
3.02
1.58
2.2
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
125
1027
1.27
1.58
1.5
1.4
g/l
4.1
2.5
6.45
99
684
(3002582) Erythrocytes [#/volume] in Urine
164
1392
1.24
1.57
3.1
2.8
e6/l
325.2
96.1
0.33
131
1070
(3007853) Bacteria identified in Skin by Aerobe culture
76
585
1.34
1.55
2.0
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
130
1.72
1.55
3.7
2.6
u/ml
0.4
0.3
0.36
13
68
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
143
0.41
1.53
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
144
0.41
1.53
1.5
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
43
0.00
1.52
0.0
2.7
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
11
51
2.18
1.51
1.3
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
21
2.87
1.51
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
128
0.39
1.50
1.4
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
42
588
0.69
1.50
1.2
1.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
61
456
1.37
1.50
10.1
10.2
g/l
119.8
124.2
0.76
61
440
(3019060) Gas panel - Arterial blood
43
303
1.45
1.47
6.6
6.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
62
467
1.36
1.46
1.3
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
133
1.68
1.44
1.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
45
616
0.71
1.42
1.3
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
178
1544
1.21
1.37
1.4
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
91
732
1.28
1.37
1.9
1.9
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
23
2.62
1.37
1.2
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
31
450
0.67
1.35
3.7
3.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
42
576
0.71
1.35
1.3
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
38
0.00
1.34
0.0
2.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
42
2.16
1.34
2.4
2.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
148
0.47
1.33
1.1
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
30
201
1.52
1.32
1.4
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
83
1.83
1.32
1.1
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
98
1.76
1.32
1.1
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
40
285
1.43
1.31
1.3
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
61
780
0.76
1.26
2.5
2.5
e6/l
1.7
0.9
0.37
21
429
(4281824)
8
37
2.18
1.21
1.4
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
517
4968
1.24
1.21
3.7
4.1
mmol/l
6.2
5.9
2.01
490
4613
(3009261) Glucose [Presence] in Urine by Test strip
267
2427
1.18
1.20
3.2
3.0
estimate
0.0
0.0
0.00
161
427
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
188
1660
1.19
1.19
3.1
2.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
126
0.47
1.18
1.5
1.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
126
0.47
1.18
1.5
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
126
0.47
1.18
1.7
1.8
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
126
0.47
1.18
1.5
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
127
0.47
1.18
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
127
0.47
1.18
1.5
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
74
593
1.28
1.17
4.6
3.1
umol/l
14.5
8.5
0.82
66
527
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
493
4721
1.21
1.16
5.0
5.2
mmol/mol
40.4
39.5
1.03
475
4460
(3036603) Volume of Urine
0
34
0.00
1.16
0.0
1.6
—
1527.3
—
0
7
(3006270) Folate [Moles/volume] in Blood
0
34
0.00
1.16
0.0
1.1
—
415.4
—
0
29
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
20
2.51
1.15
6.2
3.0
—
—
—
0
0
(3044889) 12 lead EKG panel
377
3531
1.17
1.14
2.6
3.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
36
0.00
1.14
0.0
2.7
—
19.0
—
0
29
(3021601) Nitrite [Presence] in Urine by Test strip
263
2398
1.17
1.12
3.8
4.2
estimate
0.0
0.0
0.50
169
456
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
25
168
1.51
1.11
2.7
2.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
139
0.50
1.10
1.4
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
9
166
0.54
1.09
2.6
2.3
u/ml
34.8
50.2
—
9
161
(3004588) Protein electrophoresis panel - Serum or Plasma
35
253
1.41
1.09
1.3
2.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
59
741
0.77
1.08
2.8
2.6
e6/l
2.6
1.8
0.29
22
392
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
59
1.88
1.08
2.3
3.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
262
2394
1.16
1.08
3.2
3.0
estimate
0.0
0.0
0.00
171
442
(40760888) Immunoglobulin light chains.free panel - Serum
16
97
1.67
1.07
1.3
3.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
33
2.13
1.06
1.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
79
650
1.25
1.02
2.2
2.5
ug/g
189.2
126.6
0.67
67
536
(3000991) Gas panel - Venous blood
52
406
1.31
1.01
10.5
9.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
40
301
1.35
1.00
1.8
1.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
152
1338
1.18
0.99
2.8
2.5
umol/l
372.5
5813.4
4.21
133
1203
(3008295) Osmolality of Serum or Plasma
9
49
1.85
0.99
1.3
1.3
mosm/kgh2o
278.7
283.7
—
9
39
(3000494) Fungus identified in Specimen by Culture
76
626
1.24
0.98
1.3
1.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.0
—
2.9
—
0
9
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
7.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
32
0.00
0.95
0.0
2.7
—
739.7
—
0
32
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
17
109
1.58
0.94
1.1
1.1
mmol/l
3.7
3.8
0.38
17
104
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
505
5209
0.84
0.93
3.7
4.1
mmol/l
1.4
1.4
0.93
484
4898
(40768804) Tissue Pathology biopsy report
165
1838
0.86
0.90
1.8
2.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
20
135
1.50
0.90
3.4
1.7
nmol/l
0.9
0.9
0.21
14
123
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
48
378
1.29
0.90
1.9
2.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
103
0.48
0.90
1.6
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
104
0.48
0.89
1.6
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
105
0.47
0.89
1.6
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
487
5032
0.85
0.88
3.5
3.8
mmol/l
1.5
1.4
3.33
465
4721
(3001019) Free T4 and TSH panel - Serum or Plasma
22
310
0.70
0.88
1.7
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
24
332
0.71
0.86
1.4
1.3
u/ml
520.3
290.5
0.49
24
305
(3015377) Calcium [Moles/volume] in Serum or Plasma
160
1431
1.16
0.86
2.2
3.3
mmol/l
2.3
2.3
0.10
142
1285
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
46
1.75
0.82
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
46
1.75
0.82
1.1
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
163
0.61
0.79
1.2
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
24
0.00
0.79
0.0
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
142
1267
1.16
0.79
3.5
4.3
ph
7.4
7.4
5.74
68
245
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
97
0.51
0.78
1.8
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
26
0.00
0.78
0.0
3.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
124
0.56
0.78
1.0
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
18
123
1.48
0.78
1.2
1.2
mg/l
446.1
500.2
0.55
18
117
(3003740) Influenza virus B Ag [Presence] in Specimen
7
125
0.56
0.78
1.0
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
28
0.00
0.76
0.0
2.2
—
18.1
—
0
23
(3036071) Salmonella sp Ab [Titer] in Serum
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
22
300
0.72
0.75
1.0
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
177
1614
1.13
0.72
3.6
3.3
e6/l
41.6
99.6
1.12
136
1146
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
10
158
0.63
0.71
1.6
2.2
mg/l
6.2
11.4
—
10
149
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
158
0.63
0.71
2.1
3.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
57
1.59
0.71
1.0
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
18
126
1.44
0.71
1.2
3.0
ratio
1.4
1.2
0.78
13
11
(4035726)
30
386
0.77
0.70
1.6
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
19
262
0.72
0.70
4.0
4.8
ng/l
112.9
89.4
0.25
14
238
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
5
27
1.86
0.68
2.4
1.3
—
17.2
—
0
6
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
27
1.86
0.68
3.0
3.8
u/ml
16.0
59.3
—
5
27
(3026389) Candida sp identified in Specimen by Organism specific culture
7
42
1.67
0.68
1.0
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
102
1.48
0.68
3.5
2.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
510
5226
0.87
0.67
3.7
4.2
mmol/l
4.5
4.7
4.19
483
4929
(44813793)
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
5
28
1.79
0.66
1.2
1.0
ng/l
193.8
232.4
—
5
16
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
5
28
1.79
0.66
1.2
1.0
ng/l
860.8
606.6
—
5
17
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
44
1.60
0.65
1.0
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
61
518
1.20
0.63
1.5
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
23
173
1.34
0.62
2.3
2.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
5
30
1.67
0.61
1.2
1.2
—
1.0
—
0
13
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
23
174
1.33
0.61
1.9
2.5
u/l
5902.4
3364.0
—
8
76
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.8
—
198.0
—
0
20
(3004616) Nuclear Ab [Presence] in Serum
8
52
1.55
0.59
1.4
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
8
52
1.55
0.59
1.3
2.9
mmol/l
4.1
4.0
—
8
52
(3035285) Chloride [Moles/volume] in Venous blood
8
52
1.55
0.59
1.3
2.9
mmol/l
103.9
105.3
—
8
52
(3035933) Granulocytes/100 leukocytes in Blood
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
87
0.57
0.56
1.2
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
5
88
0.56
0.56
1.0
1.1
—
11.5
—
0
8
(3050129) First trimester maternal screen panel - Serum or Plasma
11
160
0.68
0.56
1.2
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
90
0.55
0.56
1.0
1.2
u/l
14.4
31.9
—
5
78
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
63
725
0.85
0.55
2.7
2.9
mmol/l
2.5
2.4
0.71
56
639
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
167
1801
0.90
0.54
3.1
3.6
%
19.3
21.0
0.66
78
729
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
17
126
1.36
0.52
1.1
1.3
u/ml
219.6
280.0
—
7
79
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
12
165
0.72
0.47
1.2
1.1
—
5.9
—
0
22
(3019832) Treponema pallidum Ab [Presence] in Serum
65
573
1.15
0.46
1.6
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
83
0.60
0.46
1.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
85
0.58
0.45
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
50
1.40
0.45
1.0
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
23
185
1.25
0.42
1.5
1.2
—
2.6
—
0
11
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
30
358
0.83
0.41
2.3
2.4
—
18.4
—
0
29
(1617658) Protocol used for examination of sentinel lymph nodes
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
260
0.80
0.41
13.5
12.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
59
522
1.14
0.41
1.5
1.8
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
3.1
—
38.6
—
0
12
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
15
115
1.31
0.39
1.1
1.2
—
—
—
0
0
(4133840)
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
19
0.00
0.39
0.0
1.5
—
52.8
—
0
19
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
124
1.30
0.39
1.3
1.4
—
—
—
0
0
(3013512) EKG study
118
1272
0.91
0.39
4.5
3.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
98
1.33
0.37
3.6
3.3
—
2828.2
—
0
10
(1616796) Gas panel - Central venous blood
13
98
1.33
0.37
6.2
3.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
113
0.70
0.37
1.5
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
77
0.65
0.36
1.2
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
43
1.40
0.35
1.7
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
73
1.38
0.34
1.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
32
371
0.86
0.34
2.3
3.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
173
1.22
0.33
1.2
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
89
0.67
0.33
1.5
1.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
74
1.36
0.32
1.7
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
22
184
1.20
0.31
1.8
1.7
—
207.5
—
0
8
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
212
1.19
0.30
1.0
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
26
303
0.85
0.30
2.0
1.9
nmol/l
40.5
37.8
0.24
26
294
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
14
174
0.80
0.30
2.9
2.1
ug/l
1.0
3.1
0.71
14
161
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
216
2242
0.94
0.27
3.6
4.1
ug/l
2.4
1.9
0.87
193
2055
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
66
1.21
0.27
1.0
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
67
1.20
0.26
1.0
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
67
1.20
0.26
1.0
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
67
1.20
0.26
1.0
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
67
1.20
0.26
1.0
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
67
1.20
0.26
1.0
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
77
1.30
0.26
1.0
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
36
320
1.13
0.26
1.4
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
38
1.32
0.23
2.6
3.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
5
39
1.28
0.23
1.0
1.1
mg/l
318.8
266.8
—
5
32
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
5
39
1.28
0.23
1.2
1.1
mg/l
42.9
38.4
—
5
28
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
42
1.19
0.21
3.6
1.5
g/l
1.1
1.0
—
5
42
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.2
—
2.0
—
0
12
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
1.4
—
0
6
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
14
0.00
0.20
0.0
1.3
—
0.4
—
0
9
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
20.4
—
0
14
(3052851) Hemolysis interference index of Serum or Plasma
12
144
0.83
0.20
1.8
3.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.19
1.5
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
24
270
0.88
0.19
1.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
63
1.11
0.17
1.3
1.2
—
—
—
0
0
(4268621)
7
63
1.11
0.17
1.7
2.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
68
0.73
0.17
1.6
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
194
0.87
0.17
2.6
2.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
11
130
0.84
0.16
1.2
1.9
iu/l
2.0
5.9
—
6
42
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
86
0.81
0.14
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
86
0.81
0.14
1.3
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
128
0.86
0.13
2.4
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
306
1.08
0.13
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
18
161
1.12
0.13
1.4
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
148
0.88
0.12
1.3
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
83
797
1.05
0.12
1.3
1.3
u/ml
3.2
10.0
2.07
56
330
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
17
153
1.11
0.11
2.5
2.3
%
205.7
185.7
0.29
17
148
(4010399)
32
341
0.94
0.10
1.2
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
18
164
1.10
0.10
2.3
2.1
%
80.3
89.1
0.63
18
154
(21494434) Karyotype in Bone marrow
5
45
1.11
0.10
1.6
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
135
1.11
0.09
1.1
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
46
1.09
0.09
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
34
360
0.94
0.09
2.3
2.4
e9/l
3.7
4.2
0.56
19
303
(3051611) Lipemic interference index of Serum or Plasma
5
48
1.04
0.09
2.6
3.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
55
1.09
0.09
1.5
2.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
55
1.09
0.09
1.3
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
56
1.07
0.08
1.8
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
58
1.03
0.08
1.0
1.3
nmol/l
—
—
—
0
0
(4062490)
6
58
1.03
0.08
1.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
113
0.88
0.08
1.4
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
62
0.80
0.08
1.0
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
65
1.08
0.08
1.4
2.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
67
1.05
0.08
1.1
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
112
0.89
0.07
1.3
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
83
0.84
0.07
1.4
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
87
1.03
0.07
1.2
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
20
187
1.07
0.06
1.2
1.4
miu/ml
242.5
230.9
—
8
94
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
100
0.90
0.06
1.2
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
109
1.10
0.06
1.7
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
17
158
1.08
0.06
3.0
2.6
g/l
3.7
3.7
0.02
17
152
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
86
844
1.02
0.04
1.2
1.3
iu/ml
27.0
29.1
0.12
28
259
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
91
1.10
0.04
1.3
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
109
1106
0.98
0.04
1.8
1.8
mg/l
1.4
1.1
0.41
83
835
(36660697) Celiac disease serology panel - Serum
39
381
1.03
0.02
1.2
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
22
228
0.96
0.02
1.9
1.9
pmol/l
193.6
225.2
1.49
22
218
(3017446) Testosterone [Moles/volume] in Serum or Plasma
67
663
1.01
0.01
2.2
2.3
nmol/l
11.7
14.1
2.11
59
604
(40768443) Skin Pathology biopsy report
18
186
0.97
0.00
1.1
1.2
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
11
105
1.05
0.00
5.5
3.8
kpa
8.6
9.1
0.25
11
105
(40768800) Prostate Pathology biopsy report
11
115
0.96
0.00
1.2
1.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
11
106
1.04
0.00
5.5
3.8
kpa
4.9
5.0
0.23
11
106
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
118
1.02
0.00
1.1
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
528
5281
1.00
0.00
3.9
4.5
mmol/l
2.6
2.8
8.40
502
4955
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806420)
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
9.7
—
0.5
—
0
7
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
7
0.00
0.00
0.0
1.3
—
106.6
—
0
7
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
5.9
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
73.6
—
0
8
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
188.6
—
0
7
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
70
1.00
0.00
2.3
2.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
65.7
—
0
6
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
0
6
0.00
0.00
0.0
8.2
—
44.3
—
0
6
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
87
0.92
0.00
1.1
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
89
0.90
0.00
1.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
6
67
0.89
0.00
1.0
1.4
nmol/l
0.8
0.5
—
6
61
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
42.2
—
0
5
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
59
0.85
0.00
1.4
1.1
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
5.8
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4306422)
9
89
1.01
0.00
1.1
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
2.0
—
0.4
—
0
5
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
68
0.88
0.00
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
-0.00
0.0
10.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
9
0.00
-0.00
0.0
3.7
—
48.0
—
0
9
(3022689) Creatine [Moles/volume] in Urine
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_ALCOHOL_ABUSE_COUNSELLI_SURVE – Alcohol abuse counselling and surveillance

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).